Photomedicine is an interdisciplinary branch of medicine that involves the treatment and diagnosis of diseases and other complications related to health by using photobiology and light. Photomedicine treatment is done by exposing the individual to light with specific wavelengths using lasers, fluorescent lamps, full-spectrum light, polychromatic polarized light, light-emitting diodes and dichroic lamps. Moreover, photomedicine also includes the cellular and molecular mechanisms of pharmacology, chemistry, physiology and pathology as they apply to photobiology. Photomedicine has found its application in the diagnosis and treatment of heart diseases, cancer and several infections. This new treatment option of photomedicine helps better visualization and has outpaced the traditional method of diagnosing and detecting a disease.
Photomedicine Market: Drivers & Restraints
The market for photomedicine is expected to boom as there is more adoption of minimally invasive procedures, advances in medical aesthetic technologies, more augmented research funding for photomedicine, and the development of compact, versatile and multifunctional photomedicine devices. Researches in the field of photomedicine to explore newer application is bringing in more investments. Researchers from the Massachusetts General Hospital proved that by using low-level laser therapy there was enhanced platelet production in animals with thrombocytopenia as compared to normal control. Thrombocytopenia is caused due to side-effects of certain drugs, leukemia, and drugs used for chemotherapy. Platelet transfusion is the established treatment for this but only used in severe cases since its risks complications include immunosuppression, allergic reaction and infection.
Photomedicine Market: Segmentation
Photomedicine market is classified on the basis of technology, application and region.
Based on technology the photomedicine market is segmented into the following:
Polychromatic Polarized Light
Full Spectrum Light
Light Emitting Diodes
Cold lasers also known as low-level lasers emit through its low-powered laser light do not heat the target tissues. These lasers are used to improve conditions related to wound healing, pain management and conditions related to stroke and neurodegenerative disorders.
Based on application the photomedicine market is segmented into the following:
Photomedicine Market: Overview
The photomedicine market is expected to upsurge in the coming years owing to the number of new product approvals. Moreover, the photomedicine market is also experiencing consolidation with companies acquiring other market players. Syneron Medical Ltd. acquired New Star Lasers, Inc. to leverage on its CoolTouch family of aesthetic devices.
Photomedicine Market: Region-wise Outlook
A geographic condition regarding orthopedic trauma device market, it has been segmented into seven key regions: North America, Latin America, Eastern Europe, Western Europe, Asia-Pacific and the Middle East & Africa. North America is the leading region in the photomedicine market owing to the presence of major market player. Moreover, as compared to other regions the adoption of photomedicine in the use of treatment and diagnosis is higher. This is due to the higher rate of research undertakings and the grants received to explore this area of medicine. Asia Pacific is also emerging region due to the developing economies. Moreover as it has a strong presence for foreign tourism, there has been a growing adoption of photomedicine. For instance, Lumenis Ltd. who manufactures energy-based devices for ophthalmology, surgical and aesthetic application supported a mission to treat burn injuries in Armenia. Through its Lumenis UltraPulse to treat children with burn injuries. The company’s 2015 mission included the establishment of medical laser center in Arabkir Pediatric Hospitals.
Photomedicine Market: Some of the players in photomedicine market are
Lumenis Ltd., PhotoMedex, Inc., THOR Photomedicine Ltd, Asclepion Laser Technologies GmbH, Alma Lasers, QBMI Photomedicine, IRIDEX Corporation, Syneron Medical Ltd., AngioDynamics and Spectranetics.
Companies are bringing in new product technologies in photomedicine that can aid deep penetration and help in skin regeneration and other disorders. For instance, NovoTHOR Whole Body Light Pod was introduced by THOR Photomedicine. The product which uses photobiomodulation technique was launched in partnership with English Premier League soccer teams, U.S. and UK Military forces and the Harvard Medical School.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, technology and applications.
The report covers exhaustive analysis on:
Supply & Demand
Competition & Companies involved
Regional analysis includes
North America (U.S., Canada)
Latin America (Mexico, Brazil)
Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
Asia Pacific Excluding Japan (China, India, Australia & New Zealand)
Middle East and Africa (GCC, S. Africa, Rest Of MEA)
Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint.
NOTE - All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Future Market Insights.